Impact of COVID-19 on diagnoses, monitoring and mortality in people with Type 2 diabetes in the UK

Matthew J. Carr; Alison Wright; Lalantha Leelarathna; Hood Thabit; Nicola Milner; Naresh Kanumilli; Darren Ashcroft; Martin K. Rutter

Impact of COVID-19 on diagnoses, monitoring and mortality in people with Type 2 diabetes in the UK

Matthew J. Carr, Alison Wright, Lalantha Leelarathna, Hood Thabit, Nicola Milner, Naresh Kanumilli, Darren Ashcroft, Martin K. Rutter

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	The Lancet Diabetes and Endocrinology
Publication status	Accepted/In press - 19 Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Embargoed Document

Manuscript_19April21_tracked_changes_accepted
Accepted author manuscript, 123 KB
Embargo ends: 1/01/31

Cite this

@article{cd2ff06458104b3f9b904a4e5ff2fc45,

title = "Impact of COVID-19 on diagnoses, monitoring and mortality in people with Type 2 diabetes in the UK",

author = "Carr, \{Matthew J.\} and Alison Wright and Lalantha Leelarathna and Hood Thabit and Nicola Milner and Naresh Kanumilli and Darren Ashcroft and Rutter, \{Martin K.\}",

year = "2021",

month = apr,

day = "19",

language = "English",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Impact of COVID-19 on diagnoses, monitoring and mortality in people with Type 2 diabetes in the UK

AU - Carr, Matthew J.

AU - Wright, Alison

AU - Leelarathna, Lalantha

AU - Thabit, Hood

AU - Milner, Nicola

AU - Kanumilli, Naresh

AU - Ashcroft, Darren

AU - Rutter, Martin K.

PY - 2021/4/19

Y1 - 2021/4/19

M3 - Letter

SN - 2213-8587

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

ER -